ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
42
views
0
references
Top references
cited by
268
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
1
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,671
similar
All similar
Record
: found
Abstract
: found
Article
: found
The discovery of receptor tyrosine kinases: targets for cancer therapy.
Author(s):
Andreas Gschwind
1
,
Oliver M Fischer
,
Axel Ullrich
Publication date
(Electronic):
May 2004
Journal:
Nature reviews. Cancer
Publisher:
Springer Science and Business Media LLC
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Cancer Metabolism
Author and article information
Journal
Journal ID (iso-abbrev):
Nat Rev Cancer
Title:
Nature reviews. Cancer
Publisher:
Springer Science and Business Media LLC
ISSN:
1474-175X
ISSN (Print):
1474-175X
Publication date (Electronic):
May 2004
Volume
: 4
Issue
: 5
Affiliations
[
1
]
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
Article
Publisher Item ID:
nrc1360
DOI:
10.1038/nrc1360
PubMed ID:
15122207
SO-VID:
79f6070b-bf1c-45ec-9294-6e2cf0adf25f
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,671
Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases.
Authors:
Yasuhiro Minami
,
Isao Oishi
,
Mitsuharu Endo
…
The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo.
Authors:
Thomas Dechiara
,
David C. Bowen
,
David M. Valenzuela
…
Risk of hepatitis B reactivation under treatment with tyrosine-kinase inhibitors for chronic myeloid leukemia.
Authors:
Ester Orlandi
,
Chiara Elena
,
Elisa Bono
See all similar
Cited by
257
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Authors:
Martine Piccart-Gebhart
,
Marion Procter
,
Brian Leyland-Jones
…
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer
Authors:
Suniti Misra
,
Vincent C Hascall
,
Roger Markwald
…
PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy
Authors:
Nahal Haddadi
,
Yiguang Lin
,
Glena Travis
…
See all cited by
Version 1
- Current
Version 1